1. Home
  2. Present
  3. Speakers
SPEAKERS

 


  • PTLD and Iatrogenic Lymphoproliferative Disorders: Insights From a Clinician Perspective

    Jennifer Amengual, MD

    Columbia University Irving Medical Center

  • Epstein-Barr Virus-Driven Oncogenesis



    Shannon Kenney, MD

    University of Wisconsin School of Medicine and Public Health

  • Immunomodulatory Drug (IMiD)-Associated Neoplasia: From Older Drugs to New Agents

    Mark Blaine Geyer, MD

    Memorial Sloan Kettering Cancer Center




  • CHIP and Its Relationship to Hematopoietic Neoplasms



    Siddhartha Jaiswal, MD, PhD

    Stanford University School of Medicine

  • Primary Immune Deficiencies: Updates, New Directions, and Role of Clinician-Pathologist Collaboration

    Kathleen Sullivan, MD, PhD

    Children's Hospital of Philadelphia